In vitro and ex vivo investigations are warranted to explore the response of IL-15/IL-15Rα-producing cells to TNF-α inhibitors, as well as to other immunomodulatory approaches that could be offered to SJS/TEN patients. The gene discussed is TNF; the disease is toxic epidermal necrolysis.